Traws Pharma, Inc. Common Stock (NASDAQ: TRAW) last traded at $0.445, down 7.31% on the session. The quote above updates while this page is open; the figures below are drawn from Traws Pharma, Inc. Common Stock’s own filings and are restated only when a new one is published.
Traws Pharma, Inc. Common Stock trades on NASDAQ under the ticker TRAW. Its market capitalisation is $6.84 million.
Valuation measures for Traws Pharma, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $6.84M |
|---|---|
| Enterprise value | $11.60M |
| Price / sales | 2.36 |
| Price / book | 4.05 |
| Beta | 1.45 |
Trailing-twelve-month figures tagged in Traws Pharma, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.90M |
|---|---|
| Net income (TTM) | -$21.57M |
| EPS (TTM) | -$1.85 |
| Operating margin | -742.13% |
| Return on equity | -1275.34% |
| Cash | $5.02M |
Range and volume for TRAW over the past 52 weeks.
| 52-week high | $3.23 |
|---|---|
| 52-week low | $0.430 |
| Volume | 689.9K |
| Average volume | 570.8K |
| Previous close | $0.480 |
Invest a chosen dollar amount in Traws Pharma, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TRAW.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.